UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bismuth Concentrations in Patients Treated in Real-Life Practice with a Bismuth Subcitrate-Metronidazole-Tetracycline Preparation: The SAPHARY Study

Drug safety, 2019-08, Vol.42 (8), p.993-1003

2019

Volltextzugriff (PDF)

Aversive emotion rapidly activates orexin neurons and increases heart rate in freely moving mice

Molecular brain, 2021-06, Vol.14 (1), p.104-104, Article 104

2021

Volltextzugriff (PDF)

Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation

Molecular cancer, 2017-02, Vol.16 (1), p.36-36, Article 36

2017

Volltextzugriff (PDF)

Bacterial contaminants of stored blood and blood components ready for transfusion at blood banks in Mekelle, Northern Ethiopia

BMC research notes, 2019-03, Vol.12 (1), p.169-169, Article 169

2019

Volltextzugriff (PDF)

State-transition modeling of blood transcriptome predicts disease evolution and treatment response in chronic myeloid leukemia

Leukemia, 2024-04, Vol.38 (4), p.769-780

2024

Volltextzugriff (PDF)

Tau reduction in aged mice does not impact Microangiopathy

Acta neuropathologica communications, 2020-08, Vol.8 (1), p.137-137, Article 137

2020

Volltextzugriff (PDF)

Evaluation of direct drug susceptibility testing of blood culture isolates comparing it with conventional disk diffusion testing

Journal of the Pakistan Medical Association, 2020-01, Vol.70 (1), p.105-109

2020

Volltextzugriff (PDF)

Prevalence, Haematological Alterations and Chemotherapy of Bovine Anaplasmosis in Sahiwal and Crossbred Cattle of District Faisalabad, Punjab, Pakistan

Pakistan journal of zoology, 2019-12, Vol.51 (6), p.2023

2019

Volltextzugriff (PDF)

The current spectrum of infections in cancer patients with chemotherapy related neutropenia

Infectious diseases journal of Pakistan, 2023-12, Vol.32 (4), p.147-153

2023

Volltextzugriff (PDF)

BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases

Oncogene, 2002-11, Vol.21 (51), p.7765-7775

2002

Volltextzugriff (PDF)

Modelling haematopoietic malignancies in the mouse and therapeutical implications

Oncogene, 2002-05, Vol.21 (21), p.3445-3458

2002

Volltextzugriff (PDF)

Rapid generation of a tetracycline-inducible BCR-ABL defective retrovirus using a single autoregulatory retroviral cassette

Leukemia, 2001-10, Vol.15 (10), p.1658-1662

2001

Volltextzugriff (PDF)

Effects of 2-[3-estrone-N-ethyl-piperazine-methyl]tetracycline (XW630) on osteoporosis in ovariectomized rats

Acta pharmacologica Sinica, 2000-03, Vol.21 (3), p.200-204

2000

Volltextzugriff (PDF)

Metalloproteinases in tumor progression. Review

Investigación clínica, 2006-06, Vol.47 (2), p.185-205

2006

Volltextzugriff (PDF)

SAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMS

PR newswire, 2024-03-12

2024

Volltextzugriff (PDF)

Ascensia Diabetes Care and Senseonics Announce 'The CGM for Real Life' Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes

Business Wire, 2023-10-09

2023

Volltextzugriff (PDF)

New Clinical Data Demonstrating the Safety and Accuracy of Eversense through 365 Days Presented at the American Diabetes Association 83rd Scientific Sessions

Business Wire, 2023-06-26

2023

Volltextzugriff (PDF)

Eversense 365 Receives FDA Clearance: The World's First One Year CGM

Business Wire, 2024-09-17

2024

Volltextzugriff (PDF)

Senseonics Announces a Collaboration with the University Hospitals Accountable Care Organization (UHACO) in Cleveland, Ohio

Business Wire, 2021-09-13

2021

Volltextzugriff (PDF)

Senseonics Announces Equity Grants To Employees Under Inducement Plan

Business Wire, 2022-10-06

2022

Volltextzugriff (PDF)

Senseonics Holdings, Inc. Announces Data From the Eversense Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes

Business Wire, 2024-03-08

2024

Volltextzugriff (PDF)

Medicare Coverage Significantly Expanded for the Eversense E3 CGM System

Business Wire, 2024-02-12

2024

Volltextzugriff (PDF)

Senseonics Announces a Positive Coverage Decision for Eversense E3 CGM from Anthem

Business Wire, 2022-08-03

2022

Volltextzugriff (PDF)

Senseonics Announces the First Patient Implant of the Eversense E3 CGM System in the U.S

Business Wire, 2022-04-06

2022

Volltextzugriff (PDF)

Senseonics Announces UnitedHealthcare Coverage of Eversense E3 CGM for Adults with Diabetes

Business Wire, 2023-06-02

2023

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Aktive Filter

KollektionNexis Uni

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(18)

Publikationsform

Sprache

Englisch
(61)
Spanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Business Wire
(41)
Nature
(3)
Investigación Clínica
(2)
Leukemia
(2)
Oncogene
(2)
Acta Neuropathologica Communications
(1)
Acta Pharmacologica Sinica
(1)
Bmc Research Notes
(1)
Drug Safety
(1)
Infectious Diseases Journal Of Pakistan
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Bismuth Concentrations in Patients Treated in Real-Life Practice with a Bismuth Subcitrate-Metronidazole-Tetracycline Preparation: The SAPHARY Study

Aversive emotion rapidly activates orexin neurons and increases heart rate in freely moving mice

Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation

Bacterial contaminants of stored blood and blood components ready for transfusion at blood banks in Mekelle, Northern Ethiopia

State-transition modeling of blood transcriptome predicts disease evolution and treatment response in chronic myeloid leukemia

Tau reduction in aged mice does not impact Microangiopathy

Evaluation of direct drug susceptibility testing of blood culture isolates comparing it with conventional disk diffusion testing

Prevalence, Haematological Alterations and Chemotherapy of Bovine Anaplasmosis in Sahiwal and Crossbred Cattle of District Faisalabad, Punjab, Pakistan

The current spectrum of infections in cancer patients with chemotherapy related neutropenia

BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases

Modelling haematopoietic malignancies in the mouse and therapeutical implications

Rapid generation of a tetracycline-inducible BCR-ABL defective retrovirus using a single autoregulatory retroviral cassette

Effects of 2-[3-estrone-N-ethyl-piperazine-methyl]tetracycline (XW630) on osteoporosis in ovariectomized rats

Metalloproteinases in tumor progression. Review

SAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMS

Ascensia Diabetes Care and Senseonics Announce 'The CGM for Real Life' Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes

New Clinical Data Demonstrating the Safety and Accuracy of Eversense through 365 Days Presented at the American Diabetes Association 83rd Scientific Sessions

Eversense 365 Receives FDA Clearance: The World's First One Year CGM

Senseonics Announces a Collaboration with the University Hospitals Accountable Care Organization (UHACO) in Cleveland, Ohio

Senseonics Announces Equity Grants To Employees Under Inducement Plan

Senseonics Holdings, Inc. Announces Data From the Eversense Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes

Medicare Coverage Significantly Expanded for the Eversense E3 CGM System

Senseonics Announces a Positive Coverage Decision for Eversense E3 CGM from Anthem

Senseonics Announces the First Patient Implant of the Eversense E3 CGM System in the U.S

Senseonics Announces UnitedHealthcare Coverage of Eversense E3 CGM for Adults with Diabetes

Aktive Filter

Suchergebnisse filtern